Stock LYTIX LYTIX BIOPHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Lytix Biopharma

Equities

LYTIX

NO0010405780

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-05-10 EDT 		5-day change 1st Jan Change
5.48 NOK +0.37% Intraday chart for Lytix Biopharma -6.48% +12.76%
04-25 Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity CI
04-10 Lytix Biopharma to Raise Up to NOK55 Million via Share Offering MT

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. LYTIX Stock
  4. Revisions Lytix Biopharma
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW